Envoy Medical COCH Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's additional paid-in capital?
- Envoy Medical (COCH) reported additional paid-in capital of $329.37M in Q1 2026.
- How has Envoy Medical's additional paid-in capital changed year-over-year?
- Envoy Medical's additional paid-in capital increased by 23.4% year-over-year, from $266.86M to $329.37M.
- What is the long-term trend for Envoy Medical's additional paid-in capital?
- Over 4 years (2020 to 2025), Envoy Medical's additional paid-in capital has grown at a 960.9% compound annual growth rate (CAGR), from $23.79K to $301.36M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.